|
2025
|
G/S
|
Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular disease... |
|
2024
|
G/S
|
Providing medical information and patient support services,
namely, providing medical informatio... |
|
|
G/S
|
Providing medical information and patient support services, namely, providing medical information... |
|
|
G/S
|
Research and development of pharmaceutical preparations; research and development of pharmaceutic... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, meta... |
|
|
Invention
|
Drug delivery device having dose indicator.
A drug delivery device includes a housing defining a... |
|
|
Invention
|
Treatment of asthma with anti-tsl p antibody.
The present disclosure, relates, in general, to me... |
|
|
Invention
|
Manufacturing process for hollow plunger rod.
A method of manufacturing a plunger of a drug deli... |
|
|
G/S
|
Pharmaceutical preparations; Pharmaceutical preparations for the treatment of inflammation and in... |
|
|
Invention
|
Formulations comprising a tris buffer and a protein.
Protein formulations and methods of making ... |
|
|
Invention
|
Vegfr-fc fusion protein formulations.
VEGFR-Fc fusion protein formulations and methods of making... |
|
|
G/S
|
Injectors for medical purposes pre-filled with
pharmaceutical preparations for treating cancer, ... |
|
|
G/S
|
Injectors for medical purposes pre-filled with pharmaceutical preparations for treating cancer, i... |
|
|
Invention
|
Systems and methods for performing a real-time assay of a sample.
Systems, and methods that faci... |
|
|
Invention
|
Aflibercept attributes and methods of characterizing and modifying thereof.
The present disclosu... |
|
|
G/S
|
Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that ... |
|
|
Invention
|
Drug delivery device.
Drug delivery devices and related arrangements are disclosed. A drug deliv... |
|
|
Invention
|
A method for equilibrating a chromatography medium. The present invention relates to a chromatogr... |
|
|
Invention
|
Antibodies with modulated glycan profiles.
This invention relates to recombinantly-expressed den... |
|
|
Invention
|
Vectors incorporating a combination of promoters driving selectable marker expression. Dual vecto... |
|
|
Invention
|
Vectors incorporating a combination of promoters driving selectable marker expression.
Dual vect... |
|
|
Invention
|
Methods of buffer preparation for a therapeutic protein formulation. The present disclosure provi... |
|
|
Invention
|
Monitoring systems and methods for injection devices. Monitoring systems for an injection device ... |
|
|
Invention
|
Alternating recirculating tangential flow (artf) filtration for cell culture media perfusion and ... |
|
|
Invention
|
Cellular assays to quantify target-independent clearance of therapeutic molecules. in vitroin viv... |
|
|
Invention
|
Charge pair mutations to enable correct heavy-light chain pairing. This application relates to th... |
|
|
Invention
|
Methods and systems for determining an impact of attributes. A computer-implemented method for de... |
|
|
Invention
|
Product quality attribute target ranges. Methods of selecting or rejecting a specification target... |
|
|
Invention
|
Methods for chromatography and chromatography medium reuse.
Disclosed herein are methods for chr... |
|
|
Invention
|
Methods for chromatography and chromatography medium reuse. Disclosed herein are methods for chro... |
|
|
Invention
|
T cell engager masking molecules. The present invention relates to T cell engager masking molecul... |
|
|
G/S
|
Pharmaceutical preparations used for the treatment of
cancer; pharmaceutical preparations used f... |
|
|
Invention
|
Methods of determining viscosity. DD of the formulation based on the measured plurality of D. |
|
|
Invention
|
Lymphotoxin beta receptor agonist binding proteins. |
|
|
Invention
|
Compositions comprising sotorasib. Provided herein are amorphous solid dispersions comprising sot... |
|
|
Invention
|
Filling process for pharmaceutical compositions. A method for reducing material usage in vessels ... |
|
|
Invention
|
Damper overfill chamber to increase functional robustness regarding variance in parts and process... |
|
|
Invention
|
5,6-fused and 6,6-fused bicyclic alcohols and ethers and compositions for use as 15-prostaglandin... |
|
|
Invention
|
6,6-fused bicyclic amides and compositions for use as 15-prostaglandin dehydrogenase modulators. ... |
|
|
Invention
|
5,6-fused bicyclic amides and compositions for use as 15-prostaglandin dehydrogenase modulators. ... |
|
|
G/S
|
Pharmaceutical preparations; Pharmaceutical preparations for the treatment of diabetes, endocrine... |
|
|
G/S
|
Downloadable and recorded software to assist health care practitioners in assessment of patients ... |
|
|
Invention
|
Insertion mechanism for drug delivery device.
An insertion mechanism for a drug delivery device ... |
|
|
G/S
|
Printed educational materials in the cardiovascular field. Online non-downloadable educational ma... |
|
|
G/S
|
Educational services, namely, providing online training, educational information, awareness, tool... |
|
|
Invention
|
Dosing of kras inhibitor for treatment of cancers.
Provided herein are methods of administering ... |
|
2023
|
Invention
|
Antibody constructs for msln and cd3.
The present invention relates to a bispecific antibody con... |
|
|
Invention
|
Anti-sclerostin antibodies and their use to treat bone disorders as part of a regimen.
The inven... |
|
|
G/S
|
Pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used fo... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment
of cancer and cardiovascular diseas... |
|
|
G/S
|
Printed educational materials in the cardiovascular field Online non-downloadable educational mat... |
|
|
G/S
|
Pharmaceutical preparations and substances for use in the
treatment of hematological, immune, au... |
|
|
G/S
|
Pharmaceutical preparations and substances for use in the treatment of hematological, immune, aut... |
|
|
G/S
|
Pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune,... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment ... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations and
substances for use in the treatment... |
|
|
Invention
|
Antibody protein product expression constructs for high throughput sequencing.
The disclosure pr... |
|
2022
|
Invention
|
Dcaf4l2-specific t-cell receptors.
Provided herein are T-cell receptors (TCRs) that when express... |
|
|
Invention
|
Stopper placement in a syringe.
A method of placing a plunger into a syringe barrel filled with ... |
|
|
Invention
|
Plunger rod removal force method and fixture.
A testing system for a drug delivery device includ... |
|
|
Invention
|
Application of natural language processing to facilitate responses to regulatory questions.
In s... |
|
|
Invention
|
Impact activated brake feature for drug delivery device.
A drug delivery device includes a housi... |
|
|
Invention
|
Impact activated retention feature for drug delivery device.
A drug delivery device includes a h... |
|
|
Invention
|
Compositions and methods for enhancing gene silencing activity of oligonucleotide compounds.
The... |
|
|
Invention
|
Characterization apparatus for drug delivery devices or subcomponents thereof.
Apparatuses, syst... |
|
|
Invention
|
Myopeptides and methods of use in treating heart failure.
Myopeptides are provided, which includ... |
|
|
Invention
|
Heterocyclic compounds and methods of use.
The present disclosure provides compounds useful for ... |
|
|
Invention
|
Systems and approaches for drug processing using single-use hardware.
A system for dispensing, i... |
|
2021
|
Invention
|
Oral suspension of apremilast.
Provided herein are suspensions for oral administration comprisin... |
|
|
Invention
|
Antibody formulations and uses thereof.
Antibody formulations and methods of making and using su... |
